An Abbott (NYSE: ABT) official said today that the company launched its latest-generation MitraClip and TriClip G5 systems.
Sandra Lesenfants, SVP of Abbott’s Structural Heart Division, announced the systems’ availability on LinkedIn:
“I am proud to share that Abbott’s MitraClip and TriClip G5 Systems are now available,” Lesenfants wrote. “This innovative system is the result of countless hours, conversations, and tireless dedication from our Structural Heart team. We constantly strive to meet physician and patient needs with quality solutions, and the G5 System exemplifies this commitment.”
Abbott Vascular’s CMO, Dr. Ethan Korngold, will share how AI is shaping Abbott’s cardiovascular portfolio at DeviceTalks West, Oct. 15–16, 2025, in Santa Clara, California. Register at West.DeviceTalks.com.
The launch comes about a month after Abbott announced a significant Medicare victory for TriClip. The company said that the Centers for Medicare and Medicaid Services (CMS) released a National Coverage Determination (NCD) and coverage conditions for tricuspid transcatheter edge-to-edge repair (T-TEER) for tricuspid regurgitation (TR). That included the TriClip TEER system.
TriClip offers an option for those who aren’t good candidates for surgery and continue to have symptoms or persistent TR despite treatment with medical therapy. Delivered through a vein in the leg, the TriClip TEER technology clips together a portion of leaflets. It repairs the tricuspid valve and helps blood flow in the right direction without the need for open-heart surgery.
MitraClip, meanwhile, offers the percutaneous reduction of significant symptomatic mitral regurgitation (MR).
Abbott says the final NCD coincides with its U.S. launch of the TriClip G5 and MitraClip G5 systems with advanced features. Both systems, with easy handling, precise positioning and intuitive deployment, have FDA approval and CE mark.
“Designed for easy handling, precise positioning, and intuitive deployment, this next-generation technology can help enhance your TEER procedures at every step,” Lesenfants said.
Abbott uses nitinol in its heart clip implants for the gripper frictional elements and leaf springs.
Nitinol innovation: Download our free special report featuring nitinol expertise and tips from medical device OEMs
